MedTech Consulting LLC（English page）
MedTech Consulting LLC
I am Toshiyuki Kanamori, the representative of MedTech Consulting LLC.
There is no doubting that the Japanese potential in science and technology is on the top level in the world and the industry activities of the research and development (R&D) are competitive to advanced countries, except in some areas, one of which is biomedical concern.
I have engaged in R&D to apply chemical engineering to medical field over 30 years. In the last two decades, I was focusing on R&D to facilitate drug discovery utilizing novel cell-based assay technology. I was pleased to help many companies which have cutting-edge technologies but don’t have know-how to expand their businesses into medical field. I was able to practically help such companies to construct suitable R&D and business models not only by giving advices but also working as a client worker.
I have so many business connections including those with major Japanese pharmaceutical companies that I am pleased to play as a bridgehead between overseas and Japanese companies.
|Name of our company||MedTech Consulting LLC|
|Representative||Toshiyuki Kanamori, Ph.D.|
|Head Office||Tsukuba, Ibaraki, Japan|
Representative of MedTech Consulting LLC
Toshiyuki KANAMORI, Ph.D.
Toshiyuki Kanamori graduated Department of Chemical Engineering, Graduate School of Science and Technology, Waseda University, and worked for an engineer of Mitsubishi Rayon Co., Ltd. After leaving the company, he was a research assistant of Waseda University and received Ph.D. degree from Waseda University. After acceptance as a senior researcher in National Institute of Material and Chemistry (NIMC) in 1994, he was focusing research and development outcome based on chemical engineering to apply to medical field in National Institute of Advanced Science and Technology, which is a following organization of NIMC. He retired AIST in March, 2022 and founded MedTech Consulting LLC in March, 2023.
He had been in many governmental positions and published 160 international scientific papers and over 40 issued patents.